Thrombophlebitis clinical trials
The registry lists 15 studies for Thrombophlebitis across more than 10 countries. 2 are recruiting or about to start. 11 of them are mainly about Thrombophlebitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-25.
Get an email when these change. Save the Thrombophlebitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institutes of Health Clinical Center (CC) (1) · Novartis (1) · Sahlgrenska University Hospital (1) · Western Galilee Hospital-Nahariya (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Centre Hospitalier le Mans (1) · University Hospital, Strasbourg, France (1)
What is being tested here
Drugs under test in Thrombophlebitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Warfarin | 0 | 1 | 2 |
| Dalteparin | 0 | 0 | 1 |
| Tissue Plasminogen Activator | 0 | 0 | 1 |
| Heparin | 0 | 0 | 1 |
| Amiodarone | 0 | 1 | 1 |
Who these studies take
Of the 1 Thrombophlebitis studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 15 studies, recruiting or not: 7% stop at 75 or younger and 7% at 65; 13% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 15 of 15. search them.
- Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Patient Safety and Quality of Intravascular Access Devices Care Management - The Safe-IVADs Project. A Longitudinell Implementation Intervention With an Embedded Process Evaluation.Not yet recruitingNCT075246081 country
- Description of Septic Thrombophlebitis on Central Venous Catheter and MidlineRecruitingNCT05743738Not applicable1 country
- Comparison of Dwell Time of Open Versus Closed Type Peripheral Intravenous CannulaCompletedNCT07182877Not applicable1 country
- Diagnostic Performance of General Practitioners in Compression UltraSoundTerminatedNCT05550038Not applicable1 country
- The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in AdultsCompletedNCT06216522Not applicable1 country
- Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking EnoxaparinStatus unknownNCT051503141 country
- Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein ThrombosisCompletedNCT00362947Phase 31 country
- Efficacy of Low Molecular Weight Heparin in Superficial Vein ThrombosisCompletedNCT01245998Phase 41 country
- Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and ToleranceCompletedNCT03470337Phase 31 country
- Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion PhlebitisCompletedNCT01943006Phase 31 country
- Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3
- Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AFStatus unknownNCT01817439Phase 31 country
- POST (Prospective Observational Superfial Thrombophlebitis)CompletedNCT008186881 country
- Treatment for Blood Clots in the Veins of the LegsCompletedNCT00001713Phase 11 country
- Topical Diclofenac Gel in Patients With Superficial Inflammation of the VeinsCompletedNCT00377806Phase 41 country